Citation Impact
Citing Papers
Infection, inflammation, height, and longevity
2005 Standout
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study
1999
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
2002
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
2004
Liver Gene Expression During Chronic Dietary Iron Overload in Rats
1990
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis
1997
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
1997 StandoutNature
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3
2001
Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools
2002
Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94
1994
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Metal-Substituted Protein MRI Contrast Agents Engineered for Enhanced Relaxivity and Ligand Sensitivity
2010 StandoutNobel
Interrelationships of alcohol and iron in liver disease with particular reference to the iron‐binding proteins, ferritin and transferrin
1999
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations
1992
Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice
1999
The β-Thalassemias
1999 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Activation of rat hepatic stellate cells leads to loss of glutathion S -transferases and their enzymatic activity against products of oxidative stress
1999
Evaluation of iron overload
2004
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Nonalcoholic Fatty Liver Disease
2002 Standout
Albumin Modified With Mannose 6–Phosphate: A Potential Carrier for Selective Delivery of Antifibrotic Drugs to Rat and Human Hepatic Stellate Cells
1999
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum
1998
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
2005
Natural history of chronic hepatitis C
2002
Morphologic Observations in Iron Overload: An Update
1994
Balancing Acts
2004 Standout
Therapy of hepatitis C: Alpha interferon and ribavirin
1997
Iron Overload in Human Disease
2012
Liver iron depletion and toxicity of the iron chelator Deferiprone (L, CP20) in the guinea pig
1997
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
2005
Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations
1998
Liver biopsy†
2008
Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
1998
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients
2018
A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations
2004
Manipulation of glutathione stores in rat hepatic stellate cells does not alter collagen synthesis
1997
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Iron metabolism
1999
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Suppressive Effects of Estradiol on Dimethylnitrosamine–Induced Fibrosis of the Liver in Rats
1999
Enhanced γ-Glutamyl Transpeptidase Expression and Selective Loss of CuZn Superoxide Dismutase in Hepatic Iron Overload
1998
Iron-induced oxidant stress in alcoholic liver fibrogenesis
2003
Primary Iron Overload in African Americans
1996
Biochemical Mechanisms for Oxygen Free Radical Formation During Exercise
1990
Liver fibrosis in genetic hemochromatosis
1992
Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.
1995
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis
1994
Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?
1989
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
1998
Expert opinion on the treatment of patients with chronic hepatitis C
2008
CD14‐positive hepatic monocytes/macrophages increase in hereditary hemochromatosis
2004
Sickle-cell disease
2010 Standout
Hepatic iron and nonalcoholic fatty liver disease
1999
Update on hepatitis C virus resistance to direct-acting antiviral agents
2014
Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
1990
EMT: 2016
2016 Standout
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
2000 StandoutNature
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Malondialdehyde–acetaldehyde–protein adducts increase secretion of chemokines by rat hepatic stellate cells
2001
Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes.
1994
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis
2011
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Glutathione regulation in rat hepatic stellate cells
1997
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
T1 and T2 of ferritin solutions: Effect of loading factor
1996
Disorders of Iron Metabolism
1999 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Staphylococcus aureusInfections
1998 Standout
Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
2000
A Population-Based Study of the Clinical Expression of the Hemochromatosis Gene
1999
Anemia of Chronic Disease
2005 Standout
Human and Rat Hepatic Stellate Cells Express Neurotrophins and Neurotrophin Receptors
2001
Replication of hepatitis C virus
2007 StandoutNobel
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Measurement of Spin‐Lattice Relaxation Times in Double Spin‐Echo Imaging
1984
Limitations of Magnetic Resonance Imaging in Measurement of Hepatic Iron
1997
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex
1991
EIN2, a Bifunctional Transducer of Ethylene and Stress Responses in Arabidopsis
1999 StandoutScience
Nuclear Magnetic Resonance Technology for Medical Studies
1984 StandoutScienceNobel
MRI of brain iron
1986
Correlation of histopathologic and bacteriologic changes with cytokine expression in an experimental murine model of bacteremic Staphylococcus aureus infection
1997
Stellate cells: A moving target in hepatic fibrogenesis†
2004
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Advances in Supramolecular Chemistry
1997
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
2005
Ribavirin as Therapy for Chronic Hepatitis C
1995
A mouse model for beta 0-thalassemia.
1995 StandoutNobel
Expression of the Na + /Ca 2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis
1998
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation
1997
AASLD position paper: Liver biopsy
2008
New therapeutic strategies in HCV: second‐generation protease inhibitors
2013
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Natural history of chronic hepatitis C
2002
Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection
2016
MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease.
1993
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of B. Bacon being referenced
Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
1988
Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C
2001
Performance Characteristics and Results of A Large–Scale Screening Program for Viral Hepatitis and Risk Factors Associated With Exposure to Viral Hepatitis B and C: Results of the National Hepatitis Screening Survey
1996
Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C
1994
Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: Diagnostic implications
1994
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
1995
Histological Evaluation of Iron in Liver Biopsies: Relationship To Hfe Mutations
2000
1151 CONTINUED HIGH VIROLOGIC RESPONSE RATES WITH ACH-1625 DAILY DOSING PLUS PEGIFN-ALPHA 2A IN A 28-DAY AND 12-WEEK PHASE 2A TRIAL
2012
Chronic iron overload causes activation of rat lipocytes in vivo
1995
Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.
1998
Nuclear magnetic resonance imaging of experimentally induced liver disease.
1983
Utilization of DAA therapies ledipasvir/sofosbuvir and sofosbuvir/ velpatasvir in patients with genotype 1 HCV: real-world experience from the TRIO Network
2017
Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical
1989
991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY
2008
Magnetic resonance imaging and spectroscopy of hepatic iron overload.
1985
Hereditary hemochromatosis: pathogenesis and clinical features of a common disease.
1989
Utilization of sofosbuvir/velpatasvir in genotype 2–6 HCV: real-world experience from the TRIO network
2017
66 HIGH SUSTAINED VIRAL RESPONSE AT 12- AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS
2013
Role of free radicals in liver diseases and hepatic fibrosis.
1994
Vitamin A-poor lipocytes: a novel desmin-negative lipocyte subpopulation, which can be activated to myofibroblasts
1995
No Effect of Proton Pump Inhibitor (PPI) Use on SVR with Ledipasvir/Sofosbuvir (LDV/SOF): Real World Data from 2034 Genotype 1 Patients in the Trio Network
2016
Pathology of dietary carbonyl iron overload in rats.
1987
TNF-alpha and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia
1994
Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon-$alpha;
1993
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
1999